Login

Unlocking Potential: Noront Resources Ltd. | Alan Coutts - CEO of Noront Resources. 00:10:00

Share On Facebook Share On Twitter

Alan Coutts is the CEO of Noront Resources.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Overview of Water and Sanitation Infrastructure Investments and Developments in Paraná | Claudio Stabile, CEO, Companhia de Saneamento do Parana Sanepar.
00:10:00
Episode In the Beginning is presented by Goliath Resources | Roger Rosmus, Founder, CEO & Director, Goliath Resources Limited (CS)
00:10:00
Anastasia Amoroso, iCapital's Chief Investment Strategist, joins 'Closing Bell' to discuss the markets, the tech sector, and its broader economic impact.
00:00:00
Micro-X (ASX:MX1): Peter Rowland, Managing Director, Micro-X Ltd
00:10:00
Manono Lithium Project Overview
00:10:00
Cordoba Minerals: Advancing Copper-Gold-Silver Projects with Strong Backing and Strategic Exploration
00:10:00
Conversations with Rajiv Jain: Navigating Market Dynamics and Investment Strategies | Rajiv Jain, Chairman , GQG Partners.
00:10:00
The explosion of fintech innovation and the mass migration to digital channels|Kabir Kumar,Director,Flourish Ventures
00:00:00
PledPharma CEO, Nicklas Westerholm
00:10:00
CI&T's company culture, as rated by their employees on Comparably, is highlighted alongside leadership lessons from USAA's President/CEO Wayne Peacock.
00:10:00
Overview of God Nine Resources' Gold Projects in the Southern Cross Greenstone Belt
00:10:00
Creating access to capital through venture capital firms, angel investors|Brooks Gibbins,Co-founder and Managing Partner,FinTech Collective

© 2017 - Neuhu+